High Expression of Tumor HLA-DR Predicts Better Prognosis and Response to Anti-PD-1 Therapy in Laryngeal Squamous Cell Carcinoma

BACKGROUND: HLA-DR is expressed in epithelial and several types of tumor cells. However, the correlation between tumor-expressed HLA-DR (teHLA-DR) and patient outcome as well as its regulation on the tumor microenvironment (TME) of laryngeal squamous cell carcinoma (LSCC) are yet to be elucidated. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Heng, Yu, Zhu, Xiaoke, Wu, Qian, Lin, Hanqing, Ding, Xuping, Tao, Lei, Lu, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192652/
https://www.ncbi.nlm.nih.gov/pubmed/37149969
http://dx.doi.org/10.1016/j.tranon.2023.101678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192652/
https://www.ncbi.nlm.nih.gov/pubmed/37149969
http://dx.doi.org/10.1016/j.tranon.2023.101678

Ejemplares similares